WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: DIVERGIMAB

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on DIVERGIMAB

Proof of use for DIVERGIMAB

We do not have any records of a proof of use for DIVERGIMAB at this moment.

Click here to add a proof of use for DIVERGIMAB

Possible trademark infringements of DIVERGIMAB

Basic Information about DIVERGIMAB

Serial Number
90826231
Filing Date
13 Jul 2021
Registration Number
7323273
Registration Date
05 Mar 2024
Mark Drawing Code
4

Classifications

Declare the trademark use of DIVERGIMAB on the blockchain with WikiTrademarks.io.

First use of DIVERGIMAB anywhere
DIVERGIMAB was first used on 13 Jul 2021 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
042
US Codes
100; 101

Who owns DIVERGIMAB?

1. AbX Biologics, Inc. Canton MA

2. AbX Biologics, Inc. Canton MA

3. AbX Biologics, Inc. Canton MA

Correspondent

Mark Leonardo NUTTER, MCCLENNEN & FISH, LLP
155 SEAPORT BOULEVARD
SEAPORT WEST
BOSTON, MA 02210

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on DIVERGIMAB